drugset / Trial / NCT00679666

Corneal Crosslinking in Keratoconus and Corneal Ectasia

NCT00679666

Phase 2/3 Withdrawn Ohio State University
RandomizedCrossoverOpen-labelTreatment

Summary

Prospective, randomized, single site to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes progressive keratoconus or corneal ectasia.

Timeline

Start
2008-04
Primary completion
2010-04
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Riboflavin Other / unclassified 1 % Topical